IL1B and HIV-1 infection: Future studies using proposed inflammasome inhibitors, including anti-IL-1β therapies such as anti-human monoclonal antibodies and IL-1 receptor antagonists, which have been used successfully to treat Cryopyrin-associated syndromes [65], might also be suitable for treating HIV-1 infection.